Somewhat Positive News Coverage Somewhat Unlikely to Affect Cyanotech (CYAN) Share Price

Media headlines about Cyanotech (NASDAQ:CYAN) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cyanotech earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 46.7853659033582 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Several research analysts have weighed in on the stock. ValuEngine raised shares of Cyanotech from a “sell” rating to a “hold” rating in a report on Monday, August 14th. TheStreet raised shares of Cyanotech from a “d” rating to a “c-” rating in a report on Monday, August 28th.

Cyanotech (NASDAQ:CYAN) traded down $0.05 during trading on Friday, hitting $4.25. 980 shares of the stock were exchanged, compared to its average volume of 3,521. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 2.36. Cyanotech has a one year low of $3.25 and a one year high of $5.35. The company has a market cap of $23.84, a P/E ratio of 69.17 and a beta of 1.06.

Cyanotech (NASDAQ:CYAN) last posted its quarterly earnings results on Monday, November 6th. The biotechnology company reported $0.08 earnings per share (EPS) for the quarter. Cyanotech had a net margin of 1.11% and a return on equity of 2.06%. The company had revenue of $8.06 million for the quarter.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at

Cyanotech Company Profile

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

Insider Buying and Selling by Quarter for Cyanotech (NASDAQ:CYAN)

What are top analysts saying about Cyanotech Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cyanotech Corporation and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit